MS Views and News Be empowered with MS views and news. To receive The MS BEACON e-Newsletter, CLICK HERE - -

Visit our MS learning channel on YouTube, which provides hundreds of MS educational videos presented by MS Experts from across the USA. Archived here: www.youtube.com/msviewsandnews -- Also please visit our Social media platforms: Facebook, Twitter, and Instagram . Each providing important information for the MS community. Furthermore, scroll down the left side of this blog to learn from the resources and links.

Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, for your personal knowledge and to keep you informed of current health-related issues. It is not a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~


Thursday, May 21, 2009

MS patients welcome close monitoring of Tysabri use

From the Chicago Tribune
Balancing drug's Risk, Rewards
The drug was like a life preserver, as Daisy Roque describes it, the first effective ally she had found in her battle against multiple sclerosis.

But when Tysabri was taken from the market in 2005 due to the appearance of a rare but deadly side effect, that preserver was pulled away from Roque, leaving her back in the thrall of the disease's progressive damage.

"It was devastating," said Roque, 35, of Crystal Lake. "It was saying 'you can't do this,' even though the drug is so wonderful, even though it was two years of having my life back."

But after the development of a unique monitoring system that allows doctors -- and Tysabri's manufacturer -- to keep close watch on every single U.S. user of the drug, it was allowed to return to market. Now, in light of encouraging results from that monitoring system presented last month, Tysabri may serve as a model for how hazardous drugs could be used safely in treating serious chronic illnesses.

Continue reading article from: Baltimore Sun.com
.
Have something to share with others? If so, please use the post comment link found below. Your name and email address would be appreciated but is not necessary unless you want a response from others. Thank You
============================================

No comments: